JP7197592B2 - ct-DNA及びBSAにおける自己組織化した銀ナノ粒子の光化学合成及び特性評価 - Google Patents
ct-DNA及びBSAにおける自己組織化した銀ナノ粒子の光化学合成及び特性評価 Download PDFInfo
- Publication number
- JP7197592B2 JP7197592B2 JP2020536092A JP2020536092A JP7197592B2 JP 7197592 B2 JP7197592 B2 JP 7197592B2 JP 2020536092 A JP2020536092 A JP 2020536092A JP 2020536092 A JP2020536092 A JP 2020536092A JP 7197592 B2 JP7197592 B2 JP 7197592B2
- Authority
- JP
- Japan
- Prior art keywords
- solution
- dna
- bsa
- silver nanoparticles
- mercaptothioxanthone
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- FOIXSVOLVBLSDH-UHFFFAOYSA-N Silver ion Chemical compound [Ag+] FOIXSVOLVBLSDH-UHFFFAOYSA-N 0.000 title claims description 36
- 230000015572 biosynthetic process Effects 0.000 title claims description 22
- 238000003786 synthesis reaction Methods 0.000 title description 13
- 238000012512 characterization method Methods 0.000 title description 2
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 claims description 33
- QAOJPYQSRMWAMC-UHFFFAOYSA-N 2-sulfanylthioxanthen-9-one Chemical compound C1=CC=C2C(=O)C3=CC(S)=CC=C3SC2=C1 QAOJPYQSRMWAMC-UHFFFAOYSA-N 0.000 claims description 27
- 239000002105 nanoparticle Substances 0.000 claims description 18
- 238000000034 method Methods 0.000 claims description 17
- 239000000203 mixture Substances 0.000 claims description 17
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims description 13
- 229910052709 silver Inorganic materials 0.000 claims description 13
- 239000004332 silver Substances 0.000 claims description 13
- 238000002371 ultraviolet--visible spectrum Methods 0.000 claims description 12
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 claims description 9
- 238000002189 fluorescence spectrum Methods 0.000 claims description 9
- 230000008859 change Effects 0.000 claims description 6
- 238000010521 absorption reaction Methods 0.000 claims description 5
- 230000001678 irradiating effect Effects 0.000 claims description 5
- 230000001225 therapeutic effect Effects 0.000 claims description 4
- 238000003384 imaging method Methods 0.000 claims description 3
- 101710134784 Agnoprotein Proteins 0.000 claims 3
- 230000001747 exhibiting effect Effects 0.000 claims 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 24
- 229940098773 bovine serum albumin Drugs 0.000 description 24
- 239000002082 metal nanoparticle Substances 0.000 description 5
- 150000003378 silver Chemical class 0.000 description 5
- 239000000463 material Substances 0.000 description 4
- 230000009467 reduction Effects 0.000 description 4
- 238000002198 surface plasmon resonance spectroscopy Methods 0.000 description 4
- -1 Thioxanthone acetic acid derivatives Chemical class 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 230000003993 interaction Effects 0.000 description 3
- 230000003287 optical effect Effects 0.000 description 3
- 230000002035 prolonged effect Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 230000002194 synthesizing effect Effects 0.000 description 3
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 3
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 102000011759 adducin Human genes 0.000 description 2
- 108010076723 adducin Proteins 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000002845 discoloration Methods 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 239000010453 quartz Substances 0.000 description 2
- 238000010526 radical polymerization reaction Methods 0.000 description 2
- 238000001338 self-assembly Methods 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 238000004073 vulcanization Methods 0.000 description 2
- MMHMYFWOECSGDR-UHFFFAOYSA-N 2,5-dimethoxybenzenesulfonamide Chemical compound COC1=CC=C(OC)C(S(N)(=O)=O)=C1 MMHMYFWOECSGDR-UHFFFAOYSA-N 0.000 description 1
- 235000013878 L-cysteine Nutrition 0.000 description 1
- 239000004201 L-cysteine Substances 0.000 description 1
- 238000000862 absorption spectrum Methods 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 238000011319 anticancer therapy Methods 0.000 description 1
- 230000008512 biological response Effects 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000004141 dimensional analysis Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 238000000295 emission spectrum Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 239000003999 initiator Substances 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 229910000510 noble metal Inorganic materials 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000000886 photobiology Effects 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000001878 scanning electron micrograph Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000004416 surface enhanced Raman spectroscopy Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- YRHRIQCWCFGUEQ-UHFFFAOYSA-N thioxanthen-9-one Chemical class C1=CC=C2C(=O)C3=CC=CC=C3SC2=C1 YRHRIQCWCFGUEQ-UHFFFAOYSA-N 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B22—CASTING; POWDER METALLURGY
- B22F—WORKING METALLIC POWDER; MANUFACTURE OF ARTICLES FROM METALLIC POWDER; MAKING METALLIC POWDER; APPARATUS OR DEVICES SPECIALLY ADAPTED FOR METALLIC POWDER
- B22F9/00—Making metallic powder or suspensions thereof
- B22F9/16—Making metallic powder or suspensions thereof using chemical processes
- B22F9/18—Making metallic powder or suspensions thereof using chemical processes with reduction of metal compounds
- B22F9/24—Making metallic powder or suspensions thereof using chemical processes with reduction of metal compounds starting from liquid metal compounds, e.g. solutions
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B22—CASTING; POWDER METALLURGY
- B22F—WORKING METALLIC POWDER; MANUFACTURE OF ARTICLES FROM METALLIC POWDER; MAKING METALLIC POWDER; APPARATUS OR DEVICES SPECIALLY ADAPTED FOR METALLIC POWDER
- B22F1/00—Metallic powder; Treatment of metallic powder, e.g. to facilitate working or to improve properties
- B22F1/05—Metallic powder characterised by the size or surface area of the particles
- B22F1/054—Nanosized particles
- B22F1/0545—Dispersions or suspensions of nanosized particles
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B22—CASTING; POWDER METALLURGY
- B22F—WORKING METALLIC POWDER; MANUFACTURE OF ARTICLES FROM METALLIC POWDER; MAKING METALLIC POWDER; APPARATUS OR DEVICES SPECIALLY ADAPTED FOR METALLIC POWDER
- B22F1/00—Metallic powder; Treatment of metallic powder, e.g. to facilitate working or to improve properties
- B22F1/07—Metallic powder characterised by particles having a nanoscale microstructure
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/25—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
- G01N21/31—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
- G01N21/33—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry using ultraviolet light
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B22—CASTING; POWDER METALLURGY
- B22F—WORKING METALLIC POWDER; MANUFACTURE OF ARTICLES FROM METALLIC POWDER; MAKING METALLIC POWDER; APPARATUS OR DEVICES SPECIALLY ADAPTED FOR METALLIC POWDER
- B22F1/00—Metallic powder; Treatment of metallic powder, e.g. to facilitate working or to improve properties
- B22F1/10—Metallic powder containing lubricating or binding agents; Metallic powder containing organic material
- B22F1/102—Metallic powder coated with organic material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/84—Systems specially adapted for particular applications
- G01N2021/8411—Application to online plant, process monitoring
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/805—Optical property
Landscapes
- Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nanotechnology (AREA)
- Pathology (AREA)
- Immunology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- General Physics & Mathematics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Crystallography & Structural Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Manufacture Of Metal Powder And Suspensions Thereof (AREA)
- Luminescent Compositions (AREA)
Description
a.ct-DNA溶液、2-メルカプトチオキサントン溶液、及びTris-HCl溶液をAgNO3溶液に加えるステップ、
b.均質になるまで、混合物を混合するステップ、
c.混合物をUVキュベットに移し、1~10cmの距離でUV光源を照射するステップ、
d.光源を照射する間、同時にUV-Vis吸収スペクトル及び蛍光発光スペクトルを取得するステップ、
e.UV-Visスペクトルで400~450nmの間にピークが観察された時に、銀ナノ粒子及び/或いは銀ナノクラスターが形成されたと結論付けるステップ。
a.BSA溶液、2-メルカプトチオキサントン溶液、及びTris-HCl溶液をAgNO3溶液に加えるステップ、
b.均質になるまで、混合物を混合するステップ、
c.混合物をUVキュベットに入れ、1~10cmの距離でUV光源を照射するステップ、
d.光源を照射する間、同時にUV-Vis吸収スペクトル及び蛍光発光スペクトルを取得するステップ、
e.吸収グラフからAgナノ粒子(AgNP)の形成を観察し、その後、Agナノクラスター(AgNC)の形成を観察するステップ。
-1mlの5×10-5Mのct-DNA溶液、0.05mlの1×10-3Mの2-メルカプトチオキサントン(TXSH)溶液、及び0.95mlのTris-HCl溶液を、1mlの1×10-3MのAgNO3溶液に加え、
-均一な分布を提供するために、総溶液量が3mlの混合物をビーカーで10分間混合し、
-ビーカーから石英製のキュベットに移した溶液に、浜松ライトニングキュアLC8スポットUV光を7cmの距離から照射し、
-照射時間に応じて、UV-Vis吸収スペクトルと蛍光発光スペクトルを同時に取得し、
-照射時間に応じて、吸収グラフからAgナノ粒子(AgNP)の形成を観察し、その後、Agナノクラスター(AgNC)の形成を観察する。
-1mlの1×10-5MのBSA溶液、0.05mlの1×10-3Mの2-メルカプトチオキサントン(TXSH)溶液、及び0.95mlのTris-HCl溶液を、1mlの1×10-3MのAgNO3溶液に加え、
-均一な分布を提供するために、総溶液量3mlの混合物をビーカーで10分間混合し、
-ビーカーから石英製のキュベットに移した溶液に、浜松ライトニングキュアLC8スポットUV光を7cmの距離から照射し、
-照射時間に応じて、UV-Vis吸収スペクトルと蛍光発光スペクトルを同時に取得し、
-照射時間に応じて、吸収グラフからAgナノ粒子(AgNP)の形成を観察し、その後、Agナノクラスター(AgNC)の形成を観察する。
Claims (4)
- 診断及び治療画像化技術の改善に使用に適した、ct-DNAにおいて1秒の短い光照射時間でも色の変化が見られる、自己組織化した銀ナノ粒子を取得する方法であって、
a)ct-DNA溶液、2-メルカプトチオキサントン溶液及びTris-HCl溶液をAgNO3溶液に加えるステップ、
ここで、
前記AgNO3溶液の濃度は、0.5×10-3M~3×10-3Mの範囲であり、
前記ct-DNA溶液の濃度は、1×10-5M~10×10-5Mの範囲であり、
前記2-メルカプトチオキサントンの溶液の濃度は、0.5×10-3M~3×10-3Mの範囲であり、
前記AgNO 3 溶液、前記ct-DNA溶液、前記2-メルカプトチオキサントン溶液、及び前記Tris-HCl溶液が、2:2:0.1:0.95の体積比で使用され、
b)均質になるまで、混合物を混合するステップ、
c)前記混合物をUVキュベットに移し、1~10cmの距離でUV光源を照射するステップ、
d)光源を照射する間、同時にUV-Vis吸収スペクトル及び蛍光発光スペクトルを取得するステップ、及び
e)UV-Visスペクトルで400~450nmの間にピークが観察された時に、銀ナノ粒子及び/或いは銀ナノクラスターが形成されたと結論付けるステップ
を含む、方法。 - 前記ステップc)で、前記混合物に1秒~150秒間、前記UV光源を照射する、請求項1に記載のct-DNAにおいて銀ナノ粒子を取得する方法。
- 診断及び治療画像化技術の改善に使用に適した、BSAにおいて1秒の短い光照射時間でも色の変化が見られる、自己組織化した銀ナノ粒子を取得する方法であって、
a)BSA溶液、2-メルカプトチオキサントン溶液、及びTris-HCl溶液をAgNO3溶液に加えるステップ、
ここで、
前記AgNO3溶液の濃度は、0.5×10-3M~3×10-3Mの範囲であり、
前記BSA溶液の濃度は、0.5×10-5M~3×10-5Mの範囲であり、
前記2-メルカプトチオキサントンの溶液の濃度は、0.5×10-3M~3×10-3Mの範囲であり、
b)均質になるまで、混合物を混合するステップ、
c)前記混合物をUVキュベットに入れ、1~10cmの距離でUV光源を照射するステップ、
d)光源を照射する間、同時にUV-Vis吸収スペクトル及び蛍光発光スペクトルを取得するステップ、
e)吸収グラフからAgナノ粒子(AgNP)の形成を観察し、その後、Agナノクラスター(AgNC)の形成を観察するステップ
を含む、方法。 - 前記ステップc)で、前記混合物に1秒~150秒間、前記UV光源を照射する、請求項3に記載のBSAにおいて銀ナノ粒子を取得する方法。
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TR201722282 | 2017-12-27 | ||
TR2017/22282 | 2017-12-27 | ||
TR2018/20232A TR201820232A1 (tr) | 2018-12-24 | 2018-12-24 | Ct-dna ve bsa üzeri̇nde kendi̇li̇ği̇nden düzenlenen gümüş nanoparçaciklarin fotoki̇myasal sentezi̇ ve karakteri̇zasyonu |
TR2018/20232 | 2018-12-24 | ||
PCT/TR2018/050921 WO2019132846A1 (en) | 2017-12-27 | 2018-12-27 | Photo-chemical synthesis and characterization of silver nanoparticles self-arranged on ct-dna and bsa |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2021509443A JP2021509443A (ja) | 2021-03-25 |
JP7197592B2 true JP7197592B2 (ja) | 2022-12-27 |
Family
ID=65520369
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2020536092A Active JP7197592B2 (ja) | 2017-12-27 | 2018-12-27 | ct-DNA及びBSAにおける自己組織化した銀ナノ粒子の光化学合成及び特性評価 |
Country Status (3)
Country | Link |
---|---|
US (1) | US11565320B2 (ja) |
JP (1) | JP7197592B2 (ja) |
WO (1) | WO2019132846A1 (ja) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111168058B (zh) * | 2020-03-18 | 2022-05-10 | 安徽师范大学 | janus金纳米棒@硫化铜纳米材料、核壳金纳米棒@硫化铜纳米材料及制备方法和应用 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2013177678A (ja) | 2012-01-31 | 2013-09-09 | Nissei Bio Kk | 銀微粒子とdnaの複合体及びその製造方法 |
JP2018512421A (ja) | 2015-03-30 | 2018-05-17 | カウンスィル オブ サイエンティフィック アンド インダストリアル リサーチCouncil Of Scientific & Industrial Research | 青色光を用いて生物有機的に被覆される金および銀ナノ粒子を調製するための方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6063259A (en) * | 1996-06-11 | 2000-05-16 | New Mexico State University Technology Transfer Corporation | Microfabricated thick-film electrochemical sensor for nucleic acid determination |
TR201009273A2 (tr) | 2010-11-09 | 2012-05-21 | Yedi̇tepe Üni̇versi̇tesi̇ | Gümüş nanoparçacık sentez yöntemi. |
CN106475572A (zh) * | 2016-09-30 | 2017-03-08 | 天津宝兴威科技有限公司 | 一种新型纳米银线的合成方法 |
-
2018
- 2018-12-27 JP JP2020536092A patent/JP7197592B2/ja active Active
- 2018-12-27 WO PCT/TR2018/050921 patent/WO2019132846A1/en active Application Filing
- 2018-12-27 US US16/957,638 patent/US11565320B2/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2013177678A (ja) | 2012-01-31 | 2013-09-09 | Nissei Bio Kk | 銀微粒子とdnaの複合体及びその製造方法 |
JP2018512421A (ja) | 2015-03-30 | 2018-05-17 | カウンスィル オブ サイエンティフィック アンド インダストリアル リサーチCouncil Of Scientific & Industrial Research | 青色光を用いて生物有機的に被覆される金および銀ナノ粒子を調製するための方法 |
Non-Patent Citations (2)
Title |
---|
A.Gebregeorgis et al.,Characterization of Silver/Bovine Serum Albumin (Ag/BSA) nanoparticles structure: Morphological, compositional, and interaction studies,Journal of Colloid and Interface Science,2013年,Volume 389, Issue 1,p. 31-41,https://doi.org/10.1016/j.jcis.2012.08.041 |
Eyup Metin et al.,In-situ formation of self-assembled Ag nanoclusters on ct-DNA in the presence of 2-mercaptothioxanthone by using UV-vis light irradiation,Journal of Photochemistry and Photobiology A: Chemistry,2017年12月08日,Volume 356,p. 1-6,https://doi.org/10.1016/j.jphotochem.2017.12.009 |
Also Published As
Publication number | Publication date |
---|---|
JP2021509443A (ja) | 2021-03-25 |
US20210053125A1 (en) | 2021-02-25 |
WO2019132846A1 (en) | 2019-07-04 |
US11565320B2 (en) | 2023-01-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Halawa et al. | Gold nanoclusters: synthetic strategies and recent advances in fluorescent sensing | |
Deng et al. | Fabrication of water-soluble, green-emitting gold nanoclusters with a 65% photoluminescence quantum yield via host–guest recognition | |
Venditti | Engineered gold-based nanomaterials: Morphologies and functionalities in biomedical applications. a mini review | |
Muhammed et al. | Growth of in situ functionalized luminescent silver nanoclusters by direct reduction and size focusing | |
Kubackova et al. | Sensitive surface-enhanced Raman spectroscopy (SERS) detection of organochlorine pesticides by alkyl dithiol-functionalized metal nanoparticles-induced plasmonic hot spots | |
Aroca et al. | Surface-enhanced Raman scattering on colloidal nanostructures | |
Hutter et al. | Microglial response to gold nanoparticles | |
JP4636454B2 (ja) | 金属ナノロッドの製造方法と用途 | |
Borghei et al. | Novel fluorometric assay for detection of cysteine as a reducing agent and template in formation of copper nanoclusters | |
CN103273079B (zh) | 一种金纳米花的制备方法及其应用 | |
Gui et al. | Recent advances in synthetic methods and applications of photo-luminescent molecularly imprinted polymers | |
Akhavan et al. | Radiation synthesis and characterization of protein stabilized gold nanoparticles | |
Rezaeian et al. | Plasmonic hyperthermia or radiofrequency electric field hyperthermia of cancerous cells through green-synthesized curcumin-coated gold nanoparticles | |
KR20130016933A (ko) | 사이클로덱스트린을 이용하여 표면증강라만산란 활성을 갖는 금속 나노입자의 제조방법 및 이에 따라 제조된 금속나노입자를 포함하는 바이오센서 | |
Mishra et al. | Aqueous growth of gold clusters with tunable fluorescence using photochemically modified lipoic acid-based ligands | |
US9821061B2 (en) | Enhanced plasmonic nanoparticles for cancer therapy and diagnostics | |
Raj et al. | Application of zinc oxide nanoflowers in environmental and biomedical science | |
Park et al. | Poly (ethylene glycol)-and carboxylate-functionalized gold nanoparticles using polymer linkages: single-step synthesis, high stability, and plasmonic detection of proteins | |
JP7197592B2 (ja) | ct-DNA及びBSAにおける自己組織化した銀ナノ粒子の光化学合成及び特性評価 | |
Li et al. | Fluorescent ultrashort nanotubes from defect-induced chemical cutting | |
Zhao et al. | Sensitive surface-enhanced Raman scattering for the quantitative detection of formaldehyde in foods using gold nanorod substrate | |
Chang et al. | Plasmonic Nanoparticles: Basics to Applications (I) | |
CN107584136B (zh) | 羧化壳聚糖-二硫苏糖醇-金纳米团簇及其制备方法 | |
Voliani | Update on gold nanoparticles | |
Yang et al. | Effects of laser penetration depth and temperature on the stability of afatinib-loaded gold nanoparticles: an optical limiting study |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A80 | Written request to apply exceptions to lack of novelty of invention |
Free format text: JAPANESE INTERMEDIATE CODE: A801 Effective date: 20200703 Free format text: JAPANESE INTERMEDIATE CODE: A80 Effective date: 20200716 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20210614 |
|
A871 | Explanation of circumstances concerning accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A871 Effective date: 20210824 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20211005 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20220104 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20220303 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20220325 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20220531 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20220926 |
|
C60 | Trial request (containing other claim documents, opposition documents) |
Free format text: JAPANESE INTERMEDIATE CODE: C60 Effective date: 20220926 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20220926 |
|
A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20221017 |
|
C21 | Notice of transfer of a case for reconsideration by examiners before appeal proceedings |
Free format text: JAPANESE INTERMEDIATE CODE: C21 Effective date: 20221020 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20221122 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20221215 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 7197592 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |